STOCKHOLDERS' DEFICIT (Details Narrative) - USD ($)					1 Months Ended	3 Months Ended	12 Months Ended
	Nov. 12, 2018	Nov. 01, 2018	Oct. 30, 2018	Oct. 19, 2018	Oct. 30, 2018	Dec. 31, 2015	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Mar. 31, 2019	Jan. 31, 2019	Dec. 21, 2018	Dec. 07, 2018	Oct. 22, 2018	Oct. 03, 2018	Sep. 25, 2018	Sep. 20, 2018	Jun. 13, 2018	May 25, 2018	May 16, 2018	May 15, 2018	May 14, 2018	May 08, 2018	May 04, 2018	May 01, 2018	Apr. 26, 2018	Apr. 17, 2018	Apr. 16, 2018	Apr. 12, 2018	Jan. 26, 2018	Jan. 24, 2018
Common stock, shares authorized (in shares)							500,000,000	500,000,000
Common stock, par value (in Dollars per share)							$ 0.001	$ 0.001
Series A convertible preferred stock, shares authorized (in shares)							2,000,000	2,000,000
Series A convertible preferred stock, par value (in dollars per share)							$ 0.001	$ 0.001
Pre Articles of Incorporation amendment authorized common stock (in shares)							125,000,000
Common stock, value							$ 201,697	$ 157,785
Note face amount							$ (98,903)	$ 152,000
Series A convertible preferred stock, shares outstanding (in shares)							13,602	13,602
Preferred stock, amount of preferred dividends in arrears							$ 187,000
Series A convertible preferred stock, liquidation preference (in dollars per share)							$ 25.00
Series A convertible preferred stock, dividend rate (in Percent)							6.50%
Valuation of dividends payable in shares, percent of the weighted average of common stock sales price on the last ten trading days ending on the third trading day prior to applicable dividend payment date (in Percent)							95.00%
Amount of dividend rate increase if distribution not made within five business days following dividend payment date (in Percent)							1.00%
Series A convertible preferred stock, dividend rate increased, if company fails to pay dividends on two consecutive dividend payment dates (in Percent)							7.50%
Series A convertible preferred stock, increased dividend rate, if company fails to pay dividends within five days of dividend payment date (in Percent)							10.00%
Preferred stock conversion price per share (in dollars per share)							$ 12.00
Minimum percent of closing stock price (in Percent)							140.00%
Notice period for Company redemption of preferred stock							30 days
Purchase price per share, percent of liquidation preference required of Company to holders of Series A Convertible Preferred Stock (in Percent)							100.00%
Purchase price per share, percent of liquidation preference required of Company on change of control (in Percent)							101.00%
Percent discounting of common stock value required if change of control triggers Company redemption of preferred stock, and Company elects to redeem via common stock issuance (in Percent)							5.00%
Purchase of preferred stock (in shares)						93,570
Payment for the purchase and cancellation of Shares of Company Series A Convertible Preferred Stock						$ 58,000
Reversal of convertible preferred stock dividend accrual						$ 331,000
Share-based compensation expense							$ 380,982	$ 89,013
Share-based compensation, options granted (in shares)							13,750,000	14,000,000
Share-based compensation, options outstanding, weighted average exercise price (in dollars per share)							$ 0.1037	$ 0.1357
Options exercisable (in shares)							9,712,500
Non Plan Option [Member]
Share-based compensation, options granted (in shares)	13,500,000
Share-based compensation, options outstanding, weighted average exercise price (in dollars per share)	$ 0.07
Description of vesting schedule	Vesting schedule of 36% on grant date and 4% each month to February 2020.
Employee Stock Option [Member]
Share-based compensation, options granted (in shares)							27,750,000	14,000,000	32,000
Share-based compensation, options outstanding, weighted average exercise price (in dollars per share)							$ 0.1037	$ 0.136	$ 0.000
Share-based compensation, options outstanding, weighted average remaining contractual term							6 years 6 months	4 years 2 months 26 days
Options outstanding aggregate intrinsic value							$ 0	$ 0
Options exercisable (in shares)							9,712,500	0
Unrecognized compensation costs related to unvested equity awards, net of estimated forfeitures							$ 536,000	$ 97,000	$ 0
Weighted average basis over a period							1 year 6 months	2 years 3 months	0 years
Employee Stock Option [Member] | $.05 per Share Price [Member] | Scientific Advisory Board Members [Member]
Common stock, par value (in Dollars per share)								$ 0.001
Share-based compensation, option awards, granted (in shares)								2,000,000
Number of options vesting on first anniversary from grant date (in shares)								500,000
Number of options vesting monthly from grant date (in shares)								62,500
Term of options vest monthly								24 months
Term of options								5 years
Employee Stock Option [Member] | $.25 per Share Price [Member] | Scientific Advisory Board Members [Member]
Common stock, par value (in Dollars per share)								$ 0.001
Share-based compensation, option awards, granted (in shares)								1,500,000
Term of options								5 years
Cumulative revenue targeted								$ 5,000,000
Vendor [Member]
Number of common stock issued																															1,242,710
Common stock, value																															$ 38,524
Vendor [Member] | Non Plan Option [Member]
Share-based compensation, options granted (in shares)		250,000
Share-based compensation, options outstanding, weighted average exercise price (in dollars per share)		$ 0.13
Number of shares vested (in shares)		62,500
Additional vesting shares (in shares)		62,500
Fettig Parties [Member]
Purchase of preferred stock (in shares)					5,000,000
Messrs. Bradford T. Adamczyk and Jonathan R. Barcklow [Member] | Non Plan Option [Member]
Share-based compensation, options granted (in shares)	5,000,000
Mr. John E. Schultz Jr [Member] | Non Plan Option [Member]
Share-based compensation, options granted (in shares)	2,500,000
Independent Consultant [Member] | Non Plan Option [Member]
Share-based compensation, options granted (in shares)	1,000,000
Financial Services Agreement [Member] | BMA Securities [Member]
Number of common stock issued																														5,000,000
Common stock, value																														$ 150,000
Subscription Agreements [Member] | Scientific Advisory Board Members [Member]
Number of common stock issued																									1,000,000
Common stock, value																									$ 60,000
Subscription Agreements [Member] | Non Affiliated Individuals [Member]
Number of common stock issued		2,000,000		2,000,000			1,000,000					1,000,000	1,000,000	500,000	1,500,000		2,000,000	2,333,333	10,000,000	333,333	500,000	500,000	2,000,000	500,000		1,500,000	1,666,667	500,000	2,000,000
Common stock, value		$ 120,000		$ 20,000			$ 60,000					$ 60,000	$ 60,000	$ 30,000	$ 90,000		$ 120,000	$ 140,000	$ 600,000	$ 20,000	$ 30,000	$ 30,000	$ 120,000	$ 30,000		$ 90,000	$ 100,000	$ 30,000	$ 120,000
Interest rate terms				The note is non-interest bearing
Frequency of periodic payment				to be paid in five monthly payments
Periodic payment				$ 20,000
Date of first required payment				Nov. 20, 2018
Note face amount				$ 100,000			$ 60,000
Subscription Agreements [Member] | Non Affiliated Individuals [Member] | Subsequent Event [Member]
Note face amount										$ 60,000
Subscription Agreements [Member] | Individual [Member]
Number of common stock issued																						3,333,333
Common stock, value																						$ 200,000
Subscription Agreements [Member] | Two Individual [Member]
Number of common stock issued																1,000,000
Common stock, value																$ 60,000
Subscription Agreements [Member] | 3 Non-Affiliated Individuals [Member] | Subsequent Event [Member]
Number of common stock issued											2,500,000
Common stock, value											$ 150,000
Mutual Release And Hold Harmless Agreement [Member] | Fettig Parties [Member]
Common stock, par value (in Dollars per share)			$ 0.001		$ 0.001
Number of common stock issued			5,000,000		5,000,000
Compensation for legal services			$ 5,000
Fees for legal services			9,825
Additional consideration			$ 2,175